PfizerCentreOne Expands Fill/Finish Services in Michigan

On Feb. 16, 2017, Pfizer CentreOne announced that it has expanded fill/finish services to its Kalamazoo, Michigan facility. Along with vial-filling of small molecules and biologics, the facility also provides vial-filling of sterile suspensions, expanding the company’s service portfolio. The Kalamazoo facility currently supplies drugs to more than 100 countries around the world.

Services at the Kalamazoo site now encompass small molecules and biologics, sterile suspensions, potent and controlled substances, aqueous and oil-based formulations, lyophilization, and vials 1–100mL; bulk formulation <1–1600 liters. The Kalamazoo facility also has dedicated, onsite technical, manufacturing science, regulatory affairs, and quality teams.

Source: PfizerCentreOne